These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 34839177

  • 1. Partial STAT5 signaling is sufficient for CD4+ T cell priming but not memory formation.
    Fleury M, Vazquez-Mateo C, Hernandez-Escalante J, Dooms H.
    Cytokine; 2022 Feb; 150():155770. PubMed ID: 34839177
    [Abstract] [Full Text] [Related]

  • 2. STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells.
    Majri SS, Fritz JM, Villarino AV, Zheng L, Kanellopoulou C, Chaigne-Delalande B, Grönholm J, Niemela JE, Afzali B, Biancalana M, Pittaluga S, Sun A, Cohen JL, Holland SM, O'Shea JJ, Uzel G, Lenardo MJ.
    J Immunol; 2018 Jan 01; 200(1):110-118. PubMed ID: 29187589
    [Abstract] [Full Text] [Related]

  • 3. Ablation of SLP-76 signaling after T cell priming generates memory CD4 T cells impaired in steady-state and cytokine-driven homeostasis.
    Bushar ND, Corbo E, Schmidt M, Maltzman JS, Farber DL.
    Proc Natl Acad Sci U S A; 2010 Jan 12; 107(2):827-31. PubMed ID: 20080760
    [Abstract] [Full Text] [Related]

  • 4. IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs.
    Seki Y, Yang J, Okamoto M, Tanaka S, Goitsuka R, Farrar MA, Kubo M.
    J Immunol; 2007 Jan 01; 178(1):262-70. PubMed ID: 17182563
    [Abstract] [Full Text] [Related]

  • 5. Frontline Science: Late CD27 stimulation promotes IL-7Rα transcriptional re-expression and memory T cell qualities in effector CD8+ T cells.
    Dong H, Buckner A, Prince J, Bullock T.
    J Leukoc Biol; 2019 Nov 01; 106(5):1007-1019. PubMed ID: 31199542
    [Abstract] [Full Text] [Related]

  • 6. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells.
    Burchill MA, Goetz CA, Prlic M, O'Neil JJ, Harmon IR, Bensinger SJ, Turka LA, Brennan P, Jameson SC, Farrar MA.
    J Immunol; 2003 Dec 01; 171(11):5853-64. PubMed ID: 14634095
    [Abstract] [Full Text] [Related]

  • 7. High common-γ cytokine receptor levels promote expression of Interleukin-2/Interleukin-7 receptor α-chains with implications on T-cell differentiation and function.
    Kim JY, Mayatepek E, Seyfarth J, Jacobsen M.
    Immunology; 2024 Sep 01; 173(1):93-105. PubMed ID: 38778445
    [Abstract] [Full Text] [Related]

  • 8. Evidence of STAT5-dependent and -independent routes to CD8 memory formation and a preferential role for IL-7 over IL-15 in STAT5 activation.
    Kemp RA, Pearson CF, Cornish GH, Seddon BP.
    Immunol Cell Biol; 2010 Feb 01; 88(2):213-9. PubMed ID: 19949423
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
    Chetoui N, Boisvert M, Gendron S, Aoudjit F.
    Immunology; 2010 Jul 01; 130(3):418-26. PubMed ID: 20465565
    [Abstract] [Full Text] [Related]

  • 10. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
    Passerini L, Allan SE, Battaglia M, Di Nunzio S, Alstad AN, Levings MK, Roncarolo MG, Bacchetta R.
    Int Immunol; 2008 Mar 01; 20(3):421-31. PubMed ID: 18270368
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.
    Hand TW, Cui W, Jung YW, Sefik E, Joshi NS, Chandele A, Liu Y, Kaech SM.
    Proc Natl Acad Sci U S A; 2010 Sep 21; 107(38):16601-6. PubMed ID: 20823247
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells.
    Riou C, Yassine-Diab B, Van grevenynghe J, Somogyi R, Greller LD, Gagnon D, Gimmig S, Wilkinson P, Shi Y, Cameron MJ, Campos-Gonzalez R, Balderas RS, Kelvin D, Sekaly RP, Haddad EK.
    J Exp Med; 2007 Jan 22; 204(1):79-91. PubMed ID: 17190839
    [Abstract] [Full Text] [Related]

  • 14. STAT5 is critical to maintain effector CD8+ T cell responses.
    Tripathi P, Kurtulus S, Wojciechowski S, Sholl A, Hoebe K, Morris SC, Finkelman FD, Grimes HL, Hildeman DA.
    J Immunol; 2010 Aug 15; 185(4):2116-24. PubMed ID: 20644163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IL-6 activates STAT5 in T cells.
    Tormo AJ, Letellier MC, Sharma M, Elson G, Crabé S, Gauchat JF.
    Cytokine; 2012 Nov 15; 60(2):575-82. PubMed ID: 22854263
    [Abstract] [Full Text] [Related]

  • 17. T cells Exhibit Reduced Signal Transducer and Activator of Transcription 5 Phosphorylation and Upregulated Coinhibitory Molecule Expression After Kidney Transplantation.
    Bouvy AP, Klepper M, Kho MM, Ijzermans JN, Betjes MG, Weimar W, Baan CC.
    Transplantation; 2015 Sep 15; 99(9):1995-2003. PubMed ID: 25769075
    [Abstract] [Full Text] [Related]

  • 18. Disparate roles for STAT5 in primary and secondary CTL responses.
    Mitchell DM, Williams MA.
    J Immunol; 2013 Apr 01; 190(7):3390-8. PubMed ID: 23440411
    [Abstract] [Full Text] [Related]

  • 19. Constitutive activation of STAT5 supersedes the requirement for cytokine and TCR engagement of CD4+ T cells in steady-state homeostasis.
    Taylor DK, Walsh PT, LaRosa DF, Zhang J, Burchill MA, Farrar MA, Turka LA.
    J Immunol; 2006 Aug 15; 177(4):2216-23. PubMed ID: 16887981
    [Abstract] [Full Text] [Related]

  • 20. A role for STAT5A/B in protection of peripheral T-lymphocytes from postactivation apoptosis: insights from gene expression profiling.
    Gatzka M, Piekorz R, Moriggl R, Rawlings J, Ihle JN.
    Cytokine; 2006 May 15; 34(3-4):143-54. PubMed ID: 16757175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.